Skip to content

Opioid-free participants had fewer hormone abnormalities at long-term follow-up

Hormone disorders were less common in opioid-free participants, but this long-term cohort comparison cannot establish why the groups differed.

By 100HP editorialAbstract-based explanation checked

Based on the published abstract. The full paper may contain additional methods, results and limitations.

The 30-second takeaway

Participants who were opioid-free at long-term follow-up had less hypogonadism, a condition involving low sex-hormone production, than those continuing opioid use. Low cortisol was also less common. These observational differences suggest possible hormonal recovery, but cannot establish that stopping opioids caused the differences or document each person's recovery.

Keep in mind

The abstract compares endocrine status between groups at follow-up; it does not report hormone trajectories for individual participants or the duration of sustained remission. That limits claims about reversibility and timing.

THE NUMBERS, WITH CONTEXT

What researchers found

3.3% vs. 26.7%

Hypogonadism prevalence (low sex-hormone production)

Opioid-free versus continuing-use participants at the 18-20-year cohort follow-up. These percentages describe how common the condition was, rather than individual recovery.

Clin Endocrinol (Oxf), 2026 · Original source ↓

How hormone disorders were assessed

According to the abstract, participants completed interviews and fasting hormone tests. Researchers used predefined laboratory and clinical criteria to identify hormone disorders, then examined associations with opioid exposure, sex and depression using statistical models.

Hormone disorders had gone unrecognized

None of the participants with hypogonadism or low cortisol had previously been diagnosed or treated for those conditions. This highlights an observed recognition gap, without testing whether a particular screening strategy improves health.

CHECK THE ORIGINAL

The original publication

Endocrinopathies and Their Recovery in a 20-Year Cohort Study of People With Heroin Dependence.

Tremonti C, Twigg SM, Mills KL et al.
Clin Endocrinol (Oxf) · 2026

PubMed ID
41735247
Record checked

AI-assisted research and writing. This explains one selected publication; it is not a complete review of everything known. Our approach.